These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 23707773

  • 21. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, Muhn P, Nicolas JC, Cavaillès V, Balaguer P.
    Biochem Pharmacol; 2006 May 14; 71(10):1459-69. PubMed ID: 16554039
    [Abstract] [Full Text] [Related]

  • 22. Chemistry domain of applicability evaluation against existing estrogen receptor high-throughput assay-based activity models.
    Nelms MD, Antonijevic T, Ring C, Harris DL, Bever RJ, Lynn SG, Williams D, Chappell G, Boyles R, Borghoff S, Edwards SW, Markey K.
    Front Toxicol; 2024 May 14; 6():1346767. PubMed ID: 38694816
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Integration of in silico methods and computational systems biology to explore endocrine-disrupting chemical binding with nuclear hormone receptors.
    Ruiz P, Sack A, Wampole M, Bobst S, Vracko M.
    Chemosphere; 2017 Jul 14; 178():99-109. PubMed ID: 28319747
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Estrogen modulates in vitro T cell responses in a concentration- and receptor-dependent manner: effects on intracellular molecular targets and antioxidant enzymes.
    Priyanka HP, Krishnan HC, Singh RV, Hima L, Thyagarajan S.
    Mol Immunol; 2013 Dec 14; 56(4):328-39. PubMed ID: 23911387
    [Abstract] [Full Text] [Related]

  • 30. Computational models to predict endocrine-disrupting chemical binding with androgen or oestrogen receptors.
    Chen Y, Cheng F, Sun L, Li W, Liu G, Tang Y.
    Ecotoxicol Environ Saf; 2014 Dec 14; 110():280-7. PubMed ID: 25282305
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Bisphenol AF is a full agonist for the estrogen receptor ERalpha but a highly specific antagonist for ERbeta.
    Matsushima A, Liu X, Okada H, Shimohigashi M, Shimohigashi Y.
    Environ Health Perspect; 2010 Sep 14; 118(9):1267-72. PubMed ID: 20427257
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression.
    Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS.
    Mol Cell Endocrinol; 2003 Aug 29; 206(1-2):13-22. PubMed ID: 12943986
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.